Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis

J.S. Smolen; M. Boers; E.C. Abadie; F.C. Breedveld; P Emery; T Bardin; N. Goel; D.J. Ethgen; B.P. Avouac; P. Durez; B. Flamion; A. Laslop; P. Miossec; S. Reiter; J.Y. Reginster

doi:https://doi.org/10.1093/rheumatology/keq413

Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis

J.S. Smolen, M. Boers, E.C. Abadie, F.C. Breedveld, P Emery, T Bardin, N. Goel, D.J. Ethgen, B.P. Avouac, P. Durez, B. Flamion, A. Laslop, P. Miossec, S. Reiter, J.Y. Reginster

Epidemiology and Data Science (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1732-1736
Journal	Rheumatology
Volume	50
Issue number	10
DOIs	https://doi.org/10.1093/rheumatology/keq413
Publication status	Published - 2011

Access to Document

https://doi.org/10.1093/rheumatology/keq413

Cite this

Smolen, J. S., Boers, M., Abadie, E. C., Breedveld, F. C., Emery, P., Bardin, T., Goel, N., Ethgen, D. J., Avouac, B. P., Durez, P., Flamion, B., Laslop, A., Miossec, P., Reiter, S., & Reginster, J. Y. (2011). Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis. Rheumatology, 50(10), 1732-1736. https://doi.org/10.1093/rheumatology/keq413

@article{d4b31379deed45f2a7bd4551d19806da,

title = "Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis",

author = "J.S. Smolen and M. Boers and E.C. Abadie and F.C. Breedveld and P Emery and T Bardin and N. Goel and D.J. Ethgen and B.P. Avouac and P. Durez and B. Flamion and A. Laslop and P. Miossec and S. Reiter and J.Y. Reginster",

year = "2011",

doi = "https://doi.org/10.1093/rheumatology/keq413",

language = "Undefined/Unknown",

volume = "50",

pages = "1732--1736",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "10",

}

Smolen, JS, Boers, M, Abadie, EC, Breedveld, FC, Emery, P, Bardin, T, Goel, N, Ethgen, DJ, Avouac, BP, Durez, P, Flamion, B, Laslop, A, Miossec, P, Reiter, S & Reginster, JY 2011, 'Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis', Rheumatology, vol. 50, no. 10, pp. 1732-1736. https://doi.org/10.1093/rheumatology/keq413

TY - JOUR

T1 - Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis

AU - Smolen, J.S.

AU - Boers, M.

AU - Abadie, E.C.

AU - Breedveld, F.C.

AU - Emery, P

AU - Bardin, T

AU - Goel, N.

AU - Ethgen, D.J.

AU - Avouac, B.P.

AU - Durez, P.

AU - Flamion, B.

AU - Laslop, A.

AU - Miossec, P.

AU - Reiter, S.

AU - Reginster, J.Y.

PY - 2011

Y1 - 2011

U2 - https://doi.org/10.1093/rheumatology/keq413

DO - https://doi.org/10.1093/rheumatology/keq413

M3 - Article

C2 - 21242246

SN - 1462-0324

VL - 50

SP - 1732

EP - 1736

JO - Rheumatology

JF - Rheumatology

IS - 10

ER -